Adverse reactions of anti-tuberculosis drugs in hospitalized patients: Incidence, severity and risk factors

Mohammad Reza Javadi, Gloria Shalviri, Kheirollah Gholami, Jamshid Salamzadeh, Golshan Maghooli, Mehdi Mirsaeidi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Tuberculosis (TB) has been a common chronic infectious disease in human communities. Besides disease-related complications, there could be serious adverse reactions due to anti-tuberculosis (anti-TB) drug therapy. Objectives: To assess the incidence and severity of adverse drug reactions (ADRs) induced by anti-TB drugs. To determine possible covariates associated with detected ADRs. Methods: All patients with respiratory TB admitted to a teaching hospital who received anti-TB drugs during the research period entered the study and were monitored for ADRs. Socio-demographic and medical history of patients were used as independent covariates. The relationship between independent covariates with frequency and severity of ADRs was analysed using multivariate logistic regression. Preliminary analyses of the Mann-Whitney, Chi-square, Kruskal-Wallis and the Fisher's exact tests were applied to determine factors unlikely associated with the independent variables. Results: Among 204 patients admitted, there were 92 patients (45.1%) with ADRs induced by anti-TB drugs. Patients with a previous history of anti-TB drugs usage (OR = 5.81, 95% confidence interval [95%CI]: 1.31-25.2), patients with a history of drug allergy (OR = 6.68, CI: 1.28-36.2), those from Afghani ethnic (OR = 4.91, 95%CI: 1.28-18.30) as well as smoker patients with concurrent diseases (OR = 19.67, CI: 1.24-341.51) had a higher rate of ADR incidence. Being female (OR = 1.63, 95%CI: 1.96-36.40) and having previous history of ADR (OR = 17.46, 95%CI: 1.96-20.42) were identified as risk factors. Conclusion: Anti-TB drugs could cause severe and frequent adverse effects. Females, those with a previous history of ADRs to anti-TB drugs and Afghani patients, should be considered as high-risk groups.

Original languageEnglish (US)
Pages (from-to)1104-1110
Number of pages7
JournalPharmacoepidemiology and Drug Safety
Volume16
Issue number10
DOIs
StatePublished - Oct 2007
Externally publishedYes

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Tuberculosis
Incidence
Pharmaceutical Preparations
Confidence Intervals
Drug Hypersensitivity
Teaching Hospitals
Communicable Diseases
Chronic Disease
Logistic Models
Demography
Drug Therapy
Research

Keywords

  • Adverse drug reaction
  • Anti-TB drugs
  • Hospitalized patients
  • Preventability
  • Severity
  • Tuberculosis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Adverse reactions of anti-tuberculosis drugs in hospitalized patients : Incidence, severity and risk factors. / Javadi, Mohammad Reza; Shalviri, Gloria; Gholami, Kheirollah; Salamzadeh, Jamshid; Maghooli, Golshan; Mirsaeidi, Mehdi.

In: Pharmacoepidemiology and Drug Safety, Vol. 16, No. 10, 10.2007, p. 1104-1110.

Research output: Contribution to journalArticle

Javadi, Mohammad Reza ; Shalviri, Gloria ; Gholami, Kheirollah ; Salamzadeh, Jamshid ; Maghooli, Golshan ; Mirsaeidi, Mehdi. / Adverse reactions of anti-tuberculosis drugs in hospitalized patients : Incidence, severity and risk factors. In: Pharmacoepidemiology and Drug Safety. 2007 ; Vol. 16, No. 10. pp. 1104-1110.
@article{76dfdbf1ca7d44b0bc2dc8662c63ab3e,
title = "Adverse reactions of anti-tuberculosis drugs in hospitalized patients: Incidence, severity and risk factors",
abstract = "Background: Tuberculosis (TB) has been a common chronic infectious disease in human communities. Besides disease-related complications, there could be serious adverse reactions due to anti-tuberculosis (anti-TB) drug therapy. Objectives: To assess the incidence and severity of adverse drug reactions (ADRs) induced by anti-TB drugs. To determine possible covariates associated with detected ADRs. Methods: All patients with respiratory TB admitted to a teaching hospital who received anti-TB drugs during the research period entered the study and were monitored for ADRs. Socio-demographic and medical history of patients were used as independent covariates. The relationship between independent covariates with frequency and severity of ADRs was analysed using multivariate logistic regression. Preliminary analyses of the Mann-Whitney, Chi-square, Kruskal-Wallis and the Fisher's exact tests were applied to determine factors unlikely associated with the independent variables. Results: Among 204 patients admitted, there were 92 patients (45.1{\%}) with ADRs induced by anti-TB drugs. Patients with a previous history of anti-TB drugs usage (OR = 5.81, 95{\%} confidence interval [95{\%}CI]: 1.31-25.2), patients with a history of drug allergy (OR = 6.68, CI: 1.28-36.2), those from Afghani ethnic (OR = 4.91, 95{\%}CI: 1.28-18.30) as well as smoker patients with concurrent diseases (OR = 19.67, CI: 1.24-341.51) had a higher rate of ADR incidence. Being female (OR = 1.63, 95{\%}CI: 1.96-36.40) and having previous history of ADR (OR = 17.46, 95{\%}CI: 1.96-20.42) were identified as risk factors. Conclusion: Anti-TB drugs could cause severe and frequent adverse effects. Females, those with a previous history of ADRs to anti-TB drugs and Afghani patients, should be considered as high-risk groups.",
keywords = "Adverse drug reaction, Anti-TB drugs, Hospitalized patients, Preventability, Severity, Tuberculosis",
author = "Javadi, {Mohammad Reza} and Gloria Shalviri and Kheirollah Gholami and Jamshid Salamzadeh and Golshan Maghooli and Mehdi Mirsaeidi",
year = "2007",
month = "10",
doi = "10.1002/pds.1468",
language = "English (US)",
volume = "16",
pages = "1104--1110",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Adverse reactions of anti-tuberculosis drugs in hospitalized patients

T2 - Incidence, severity and risk factors

AU - Javadi, Mohammad Reza

AU - Shalviri, Gloria

AU - Gholami, Kheirollah

AU - Salamzadeh, Jamshid

AU - Maghooli, Golshan

AU - Mirsaeidi, Mehdi

PY - 2007/10

Y1 - 2007/10

N2 - Background: Tuberculosis (TB) has been a common chronic infectious disease in human communities. Besides disease-related complications, there could be serious adverse reactions due to anti-tuberculosis (anti-TB) drug therapy. Objectives: To assess the incidence and severity of adverse drug reactions (ADRs) induced by anti-TB drugs. To determine possible covariates associated with detected ADRs. Methods: All patients with respiratory TB admitted to a teaching hospital who received anti-TB drugs during the research period entered the study and were monitored for ADRs. Socio-demographic and medical history of patients were used as independent covariates. The relationship between independent covariates with frequency and severity of ADRs was analysed using multivariate logistic regression. Preliminary analyses of the Mann-Whitney, Chi-square, Kruskal-Wallis and the Fisher's exact tests were applied to determine factors unlikely associated with the independent variables. Results: Among 204 patients admitted, there were 92 patients (45.1%) with ADRs induced by anti-TB drugs. Patients with a previous history of anti-TB drugs usage (OR = 5.81, 95% confidence interval [95%CI]: 1.31-25.2), patients with a history of drug allergy (OR = 6.68, CI: 1.28-36.2), those from Afghani ethnic (OR = 4.91, 95%CI: 1.28-18.30) as well as smoker patients with concurrent diseases (OR = 19.67, CI: 1.24-341.51) had a higher rate of ADR incidence. Being female (OR = 1.63, 95%CI: 1.96-36.40) and having previous history of ADR (OR = 17.46, 95%CI: 1.96-20.42) were identified as risk factors. Conclusion: Anti-TB drugs could cause severe and frequent adverse effects. Females, those with a previous history of ADRs to anti-TB drugs and Afghani patients, should be considered as high-risk groups.

AB - Background: Tuberculosis (TB) has been a common chronic infectious disease in human communities. Besides disease-related complications, there could be serious adverse reactions due to anti-tuberculosis (anti-TB) drug therapy. Objectives: To assess the incidence and severity of adverse drug reactions (ADRs) induced by anti-TB drugs. To determine possible covariates associated with detected ADRs. Methods: All patients with respiratory TB admitted to a teaching hospital who received anti-TB drugs during the research period entered the study and were monitored for ADRs. Socio-demographic and medical history of patients were used as independent covariates. The relationship between independent covariates with frequency and severity of ADRs was analysed using multivariate logistic regression. Preliminary analyses of the Mann-Whitney, Chi-square, Kruskal-Wallis and the Fisher's exact tests were applied to determine factors unlikely associated with the independent variables. Results: Among 204 patients admitted, there were 92 patients (45.1%) with ADRs induced by anti-TB drugs. Patients with a previous history of anti-TB drugs usage (OR = 5.81, 95% confidence interval [95%CI]: 1.31-25.2), patients with a history of drug allergy (OR = 6.68, CI: 1.28-36.2), those from Afghani ethnic (OR = 4.91, 95%CI: 1.28-18.30) as well as smoker patients with concurrent diseases (OR = 19.67, CI: 1.24-341.51) had a higher rate of ADR incidence. Being female (OR = 1.63, 95%CI: 1.96-36.40) and having previous history of ADR (OR = 17.46, 95%CI: 1.96-20.42) were identified as risk factors. Conclusion: Anti-TB drugs could cause severe and frequent adverse effects. Females, those with a previous history of ADRs to anti-TB drugs and Afghani patients, should be considered as high-risk groups.

KW - Adverse drug reaction

KW - Anti-TB drugs

KW - Hospitalized patients

KW - Preventability

KW - Severity

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=35649006858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35649006858&partnerID=8YFLogxK

U2 - 10.1002/pds.1468

DO - 10.1002/pds.1468

M3 - Article

C2 - 17823987

AN - SCOPUS:35649006858

VL - 16

SP - 1104

EP - 1110

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 10

ER -